Share on: 
Website: ImmunityBio
Business Area(s): 

ImmunityBio, Inc. is a privately held immunotherapy company with a portfolio of biological molecules that include albumin-linked chemotherapeutic, peptides, fusion proteins, cytokine, monoclonal antibodies, adenovirus and yeast vaccine therapies. They recently began a supercomputing collaboration with Microsoft to map out the spike protein of the novel coronavirus.

El Segundo CA
United States